Many health, medical and patient groups are protesting against proposals in the TPPA to boost patent rights and severely limit generic medicines.
PUBLIC health and patients’ groups around the world have been protesting against free trade agreements that the United States and European Union are negotiating with developing countries, because of their effects on raising the prices of medicines, including for life-threatening diseases.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
